Contact Information
Company Information
Company
Zura Bio Limited (Nasdaq: ZURA)
Annual Revenue
1070000000.0
Technologies
Cloudflare DNS
Mimecast
Outlook
Microsoft Office 365
Adobe Marketing Cloud
Remote
Keywords
immunology
inflammation
biotechnology: biological products (no diagnostic substances)
health care
biotechnology research
dual-pathway antibodies
autoimmune diseases
inflammatory diseases
monoclonal antibodies
il-17
baff
il-7r
tibulizumab
crebankitug
torudokimab
clinical trials
rheumatoid arthritis
systemic sclerosis
hidradenitis suppurativa
therapeutic innovation
patient care
drug development
biologics
immunotherapy
chronic inflammation
b-cell signaling
t-cell signaling
physician collaboration
regulatory approval
biopharmaceutical
drug efficacy
patient commitment
clinical indication
biotech
chronic disease management
safety profile
phase studies
immune response modulation
anti-inflammatory agents
subcutaneous dosing
immunological disorders
biomedical research
patient outcomes
drug safety
dual antagonism strategy
transformative therapies
disease-modifying drugs
hnnovative solutions
medical needs
pathway targeting
biotechnological advancements
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans